Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMG Managers Montag & Caldwell Growth Fund Class R (MCRGX)

19.67
Net Asset Value
-0.56%
1 Day
+14.96%
Year-to-Date
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
1.37%
Expense Ratio
Low
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation and, secondly, current income. The fund invests primarily in common stocks, convertible preferred stocks, and convertible bonds. The subadviser uses a bottom-up approach to stock selection and seeks high quality, well-established, large-cap companies that the subadviser believes are growing their near-term earnings at an above average rate. The managers define a large-cap company as one having a market capitalization of $5 billion or more at the time of acquisition. It may invest in foreign securities (directly and through depositary receipts).

Performance

1 month+1.07% 3 years+7.22%
3 months+2.86% 5 years+9.36%
1 year+11.89% Since inception+7.55%
Data through --

Peer Comparisonvs. Large growth

 MCRGXCategory
Performance 5-yr return+9.36%+13.87%
Expense ratio1.37%1.12%
Risk 5 year sharpe ratio1.061.23
Net assets$942.6M$3.3B
Average market cap$101.2B$115.9B
Average P/E26.825.2
Portfolio turnover64%64%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAMG Funds
Fund manager & tenureRonald Canakaris / 22 Years
Minimal initial investment$2,000.00
Minimum IRA investment--

Holdings

U.S. stock96.28%
Cash3.72%
International stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Consumer goods 20.99%
Energy 16.69%
Consumer service 11.42%
Healthcare 11.31%
Telecommunication 9.37%
Top 10 Holdings
Portfolio weighting
UNH UnitedHealth4.86%
FB Facebook4.41%
V Visa4.32%
AAPL Apple4.30%
MSFT Microsoft4.25%
GOOGL Google4.22%
TMO Thermo Fisher Scientific Inc3.90%
PCLN Priceline3.71%
ORCL Oracle3.69%
EW Edwards Lifesciences Corp3.35%